切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (02) : 36 -41. doi: 10.3877/cma.j.issn.978-7-900220-07-3.2007.02.012

综述

血清蛋白质组学在肿瘤研究中的现状及展望
柴凡1, 姜军1,()   
  1. 1.400038 重庆,第三军医大学西南医院乳腺中心
  • 收稿日期:2006-12-10 出版日期:2007-02-25
  • 通信作者: 姜军

Status and prospect of serum proteomics in the tumor research

Fan CHAI, Jun JIANG()   

  • Received:2006-12-10 Published:2007-02-25
  • Corresponding author: Jun JIANG
引用本文:

柴凡, 姜军. 血清蛋白质组学在肿瘤研究中的现状及展望[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(02): 36-41.

Fan CHAI, Jun JIANG. Status and prospect of serum proteomics in the tumor research[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(02): 36-41.

[1]
Wasinger V C, Humphery Smith I, Willams K L,et al. Progress with gene product mapping of the molicutes: Mycoplasma genitalium. Electrophoresis,1995,16:1090 -1094.
[2]
Anderson N L, Anderson N G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics,2002,1:845 -867.
[3]
Putnam F W. Perspectives past, present and future. In: Putnam FW, ed. The plasma proteins structure, function, and genetic control. New York Academic Press,(1975 -1987):1 -55.
[4]
Cohn E J. The history of plasma fractionation. Advances in Military Medicine,1948,1:364 -443.
[5]
Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature,1975,256:49 -57.
[6]
Pieper R, Su Q, Gatlin C L,et al. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomic,2003,3:422 -432.
[7]
Georgiou H M, Rice G E, Baker M S. Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins. Proteomics,2001,1:1503 -1506.
[8]
Tirumalai R S, Chan K C, Prieto D A,et al. Characterization of the low molecular weight human serumproteome. Mol Cell Proteomics,2003,2:1096 -1103.
[9]
Steel L F, Trotter M G, Nakajima P B,et al. Efficient and specific removal of albumin from human serum samples. Mol Cell Proteomics,2003,2:262 -270.
[10]
Zuo X, Speicher D W. Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two -dimensional electrophoresis. Proteomics,2002,2:58 -68.
[11]
Adkins J N, Varnum S M, Auberry K J,et al. Toward a human blood serumproteome: analysis by multi - dimensional separation coupled with mass spectrometry. Mol Cell Proteomics,2002,1:947-955.
[12]
O'Farrell P H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem,1975,250:4007 -4021.
[13]
Stuhler K, Meyer H E. MALDI: more than peptide mass fingerprints. Curr Opin Mol Ther,2004,6:239 -248.
[14]
Conrads T P,Hood B L,Issaq H J,et al. Proteomic patterns as a diagnostic tool for early-stage cancer: a review of it s progress to a clinically relevant tool. Mol Diagn,2004,8:77 -85.
[15]
Issaq H J, Veenstra T D, Conrads T P, et al. The SELDI-TOF MS approach to proteomics:protein profiling and biomarker identification. Biochem Biophys Res Commun,2002,292:587 -592.
[16]
Wall D B,Berger S J, Finch J W,et al. Continuous sample deposition from reversed-phase liquid chromatography to tracks on a matrix-assisted laser desorption/ionization precoated target for the analysis of protein digests. Electrophoresis,2002,23:3193 -3204.
[17]
Macbeat H G, Schreiber S L. Printing proteins as microarrays for high - throughput function determination. Science,2000,278(5485):1760 -1763.
[18]
O'Donovan C, Apweiler R, Bairoch A. The human proteomics initiative (HPI). Trends Biotechnol,2001,19:178 -181.
[19]
Berman H M, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res,2000,28:235 -242..
[20]
Bairoch A, Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Research,2000,28:45 -48.
[21]
Kawashima S,Kanehisa M. AAindex:amino acid index database.Nucleic Acids Res,2000,28(1):374.
[22]
Gavin A C, Bosche M, Krause R,et al. Functional organization of t he yeast proteome by systematic analysis of protein complexes.Nature,2002,415:141 -147..
[23]
Ho Y, Gruhler A, Bader G D,et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature,2002,415:180 -183.
[24]
Wulfkuhle J D, Sgroi D C, Krutzsch H,et al. Proteomics of humanbreast ductal carcinorma in situ. Cancer Res,2002,62:6740-6749..
[25]
Jungblut P R, Zimny-Arndt U, Zeindl-Eberhart E, et al. Proteomics in human disease: cancer, heart and infectious disease.Electrophoresis,1999,20(10):2100 -2110.
[26]
Prasannan L, Misek D E, Hinderer R,et al. Identification of betatubulin isoforms as tumour antigens in neuroblastoma. Clin Cancer Res,2000,6:3949 -3956..
[27]
Chen G, Gharib T G, Huang C C, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res,2002,8:2298 -2305..
[28]
Birchory F, Beer D, Hanash S,et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Research,2001,61:7908 -7912..
[29]
Adam B L, Qu Y, Davis J W,et al. Serum protein fingerprinting coupled with a patternmatching algorithm distinguishes prostate cancer from benign prostate hyperp lasia and healthy men. Cancer Res,2002,62:3609 -3614.
[30]
Bergman A C,Benjamin T,Alaiya A. Identification of gel-separated tumor marker protein by mass spectrometry. Electrophoresis,2000,21:679.
[31]
Alaiya A A, Franen B, Auer G,et al. Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification. Electrophoresis,2000,21:1210.
[32]
Smith R A, Cokkinides V, Eyre H J. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin,2003,53:27.
[33]
Petricoin E F,Liotta L A. Proteomic analysis at the bedside:early detection of cancer. Trends Biotechnol,2002,12:S30.
[34]
Hu Y, Zhang S, Yu J, et al. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.Breast,2005,14:250 -255.
[35]
Stierum R, Gaspari M, Dommels Y,et al. Proteome analysis reveal novel proteins associated with proliferation anddifferentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta,2003,1605:73.
[36]
Melhem R, Hailat N, Kuick R, et al. Quantitative analysis of Op18 phosphorylation in childhood acute leukemia. Leukemia,1997,11:1690.
[37]
Sinha P,Kohl S,Fischer J. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two - dimensional electrophoresis. Electrophoresis,2000,21:3048.
[38]
Chen S T, Pan T L, Tsai Y C,et al. Proteomics reveals protein profile changes in doxorubicin treated MCF 27 human breast cancer cells. Cancer Lett,2002,181:95 -107.
[39]
Ross J S, Fletcher J A, Bloom K J, et al. Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics,2004,3:379 -398.
[40]
Venter J C, Adams M D, Myers E W,et al. The sequence of the human genome. Science,2001,291:1304 -1351.
[41]
Abbott A. And now for the proteome. Nature,2001,409:747.
[42]
Fields S. Proteomics in genomeland. Science,2001,291:122.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[3] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[4] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[5] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[6] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[13] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[14] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[15] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
阅读次数
全文


摘要